{"entity":{"id":"nct03172299","kind":"trial","name":"Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma","aka":[],"tldr":"A phase 3 trial of Ziv-aflibercept in Uveal melanoma, run by Centre Hospitalier Universitaire de Nice, completed.","summary":"Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma is a phase 3 interventional study registered as NCT03172299 by Centre Hospitalier Universitaire de Nice, with 57 participants recorded, started 2017-06-08 and reaching its primary completion in 2025-01-31. Interventions recorded: Aflibercept Injection, False injection. Conditions recorded: Ocular Melanoma.\n\nLinked to the drug Ziv-aflibercept because the registry names it among its interventions and Uveal melanoma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT03172299","url":"https://clinicaltrials.gov/study/NCT03172299"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["uveal-melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":["ziv-aflibercept"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03172299","phase":"3","setting":"Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-Vascular Endothelial Growth Factor in Patients Treated with Proton Therapy for a Large Choroidal Melanoma","sponsor":"Centre Hospitalier Universitaire de Nice","enrolled":57,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03172299/","neighbours":{"cancer":[{"id":"uveal-melanoma","kind":"cancer","name":"Uveal melanoma","route":"/cancers/uveal-melanoma/"}],"drug":[{"id":"ziv-aflibercept","kind":"drug","name":"Ziv-aflibercept","route":"/drugs/ziv-aflibercept/"}]}}